Concepedia

Lili Ma

LM

Statistics

Publications

34

Citations

1.1K

H-Index

19

Active since

2011

Affiliations

Hebei University(Current)

City University of Hong Kong

City University of Hong Kong, Shenzhen Research Institute

Southern Medical University

Nanfang Hospital

Lili Ma is an author at Hebei University specializing in oncology, chemistry, and medicinal chemistry.

ORCID

Publications per year

2011–2024

34

Publications

34

Photo‐Reduction with NIR Light of Nucleus‐Targeting Pt <sup>IV</sup> Nanoparticles for Combined Tumor‐Targeted Chemotherapy and Photodynamic Immunotherapy

Dengshuai Wei, Yun Huang, Bin Wang et al. · Angewandte Chemie International Edition · 2022 · 185 citations

, , +17

Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(<scp>iv</scp>) prodrug with unique mode of action

Lili Ma, Rong Ma, Yi‐Ping Wang et al. · Chemical Communications · 2015 · 97 citations

, , +15

Platinum-containing heterometallic complexes in cancer therapy: advances and perspectives

Lili Ma, Luwei Li, Guangyu Zhu · Inorganic Chemistry Frontiers · 2022 · 79 citations

, , +17

Heterodinuclear Pt(<scp>iv</scp>)–Ru(<scp>ii</scp>) anticancer prodrugs to combat both drug resistance and tumor metastasis

Lili Ma, Rong Ma, Zhigang Wang et al. · Chemical Communications · 2016 · 76 citations

, , +13

Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt<sup>IV</sup> Anticancer Prodrug

Lili Ma, Na Wang, Rong Ma et al. · Angewandte Chemie International Edition · 2018 · 74 citations

, , +15

1–5 of 34